What is the 1470nm laser studying for androgenetic and scarring alopecia?

This study is evaluating a 1470nm non-ablative laser to see how it may affect hair loss in people with androgenetic and scarring alopecia. Researchers want to understand if this laser treatment can improve hair density and reduce hair loss. The study is led by Montefiore Medical Center and involves careful monitoring over several months.

Who may be eligible for this alopecia clinical trial?

Adults aged 18 to 99 with biopsy-proven androgenetic or scarring alopecia who have stable hair loss treatment without recent improvement may be eligible. Participants must be healthy non-smokers and able to follow the study schedule. Please review eligibility criteria for more details.

Is there any cost to participate in this alopecia clinical trial?

Study-related care, including the laser treatment and all trial visits, is provided at no cost. However, personal travel expenses and other costs may vary and are not guaranteed to be covered.

Actively Recruiting

Phase Not Applicable

Age: 18Years - 99Years

All Genders

Healthy Volunteers

ID05460611

Pilot Study of the 1470nm Non-Ablative Laser to Treat Androgenetic and Scarring Alopecia

Led by Montefiore Medical Center · Updated on 2026-06-11

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the use of a non-ablative 1470 nm laser for treating androgenetic alopecia and scarring alopecia in this single-center, open-label pilot study. The study aims to enroll up to 10 participants with biopsy-confirmed alopecia who seek improvement in hair loss. The study includes two treatment groups one for androgenetic alopecia and one for scarring alopecia, with five participants in each. Participants will receive up to three treatments using the Sciton HALO 1470nm non-ablative laser. Each treatment targets affected scalp areas and lasts approximately 10 to 15 minutes. Before treatment, a topical anesthetic and antiseptic cleaning are applied, followed by post-treatment care including topical betamethasone dipropionate cream. Treatments follow a set protocol to create controlled zones in the scalp skin to potentially enhance hair growth. Participants will have follow-up visits at months 6, 9, 12, and 15 after their initial treatment. During these visits, standardized photographs and hair density measurements using the Canfield HairMetrix device will be collected and compared to baseline. Participants will also complete questionnaires regarding pain, satisfaction, and self-assessment of hair growth. The study monitors safety and treatment effects over a total period of approximately 15 months.

CONDITIONS

Brief Title

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Who Can Participate

Age: 18Years - 99Years

All Genders

Healthy Volunteers

Eligibility Criteria

You may qualify if you...

Healthy males and females aged 18 years or older
Diagnosis of biopsy-proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
Stable hair loss treatment regimen with no improvement for at least 3 months
Able to read, understand, and voluntarily provide written informed consent
Non-smokers who agree not to change their daily hair treatment during the study
Willing and able to comply with the treatment protocol and follow-up schedule
Agree not to undergo other procedures in the treated areas through the follow-up period

You will not qualify if you...

Unable to provide informed consent
Have other types of scalp alopecia such as alopecia areata
History of intralesional steroid injections in the scalp within the last 12 months
Pregnant women
Medical conditions increasing risk of photosensitivity reactions
Previous surgery in the treatment area within the past 12 months or major surgery within 6 months
Allergy or prior reaction to lidocaine
History of immunosuppression or immune deficiency disorders, including AIDS or HIV, or systemic chemotherapy within the past 12 months
Use of immunosuppressive medications/biologics within 6 months prior to and during the study
Use of Accutane or other systemic retinoids within the past 12 months
Smoking or vaping in the past 12 months
History of uncontrolled hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders
History of major depressive or endocrine disorders including hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism

Research Team

Anika Jallorina, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Pilot Study of the 1470nm Non-Ablative Laser to Treat Androgenetic and Scarring Alopecia

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Research Team

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria